Clorox Slips as Lowered 2026 Outlook, ERP Headwinds and Leadership Changes Weigh

The Clorox Company (CLX) is down 5.0% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver is continued investor concern over Clorox’s weaker fiscal 2026 outlook, which now reflects a deeper organic sales decline, margin pressure and lower earnings expectations. Ongoing disruption from last year’s ERP-related inventory timing, added costs from the GOJO acquisition and fresh leadership changes also appear to be keeping sentiment cautious.

Details:

Clorox cut its fiscal 2026 outlook in late April, saying net sales are expected to fall about 6% and organic sales about 9%, both worse than investors had been hoping for.

Management said the biggest factor is a transitory ERP issue: retailers built inventory ahead of the system transition last year, and the current drawdown is expected to reduce fiscal 2026 earnings per share by about $0.90.

The updated outlook also includes pressure from the GOJO deal, which closed April 1, including acquisition and integration costs of about $0.30 per share and margin headwinds tied partly to inventory step-up costs.

This could also be because investors are reacting to execution risk around the management transition. Clorox said on June 17 that it is simplifying its operating structure and appointing a chief operating officer, shortly after launching a CEO search when Linda Rendle disclosed plans to step down for health reasons.

Sources:

The Clorox Company, SEC

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CLX Insider Trading Activity

$CLX insiders have traded $CLX stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $CLX stock by insiders over the last 6 months:

PIERRE R BREBER purchased 5,000 shares for an estimated $429,124

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$CLX Hedge Fund Activity

We have seen 551 institutional investors add shares of $CLX stock to their portfolio, and 570 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

STIFEL FINANCIAL CORP removed 2,378,720 shares (-78.3%) from their portfolio in Q4 2025, for an estimated $239,846,337
POINT72 ASSET MANAGEMENT, L.P. added 1,234,932 shares (+345.6%) to their portfolio in Q1 2026, for an estimated $124,672,560
TWO SIGMA INVESTMENTS, LP removed 929,055 shares (-88.2%) from their portfolio in Q1 2026, for an estimated $93,792,747
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 892,381 shares (-55.1%) from their portfolio in Q1 2026, for an estimated $90,090,323
INVESCO LTD. added 884,751 shares (+22.1%) to their portfolio in Q4 2025, for an estimated $89,209,443
FMR LLC added 822,022 shares (+127.0%) to their portfolio in Q1 2026, for an estimated $82,987,231
TWO SIGMA ADVISERS, LP removed 778,100 shares (-38.2%) from their portfolio in Q4 2025, for an estimated $78,455,823

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$CLX Congressional Stock Trading

Members of Congress have traded $CLX stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $CLX stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 05/15.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$CLX Price Targets

Multiple analysts have issued price targets for $CLX recently. We have seen 11 analysts offer price targets for $CLX in the last 6 months, with a median target of $97.0.

Here are some recent targets:

Chris Carey from Wells Fargo set a target price of $95.0 on 05/18/2026
Lauren Lieberman from Barclays set a target price of $85.0 on 05/04/2026
Javier Escalante from Evercore ISI Group set a target price of $110.0 on 05/01/2026
Andrea Teixeira from JP Morgan set a target price of $95.0 on 05/01/2026
Filippo Falorni from Citigroup set a target price of $97.0 on 05/01/2026
Peter Grom from UBS set a target price of $96.0 on 05/01/2026
Dara Mohsenian from Morgan Stanley set a target price of $110.0 on 04/23/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.